MicroRNAs as Modulators of the Immune Response in T-Cell Acute Lymphoblastic Leukemia

被引:7
|
作者
Del Gaizo, Martina [1 ]
Sergio, Ilaria [2 ]
Lazzari, Sara [1 ]
Cialfi, Samantha [1 ]
Pelullo, Maria [3 ]
Screpanti, Isabella [1 ]
Felli, Maria Pia [2 ]
机构
[1] Sapienza Univ Rome, Dept Mol Med, I-00161 Rome, Italy
[2] Sapienza Univ Rome, Dept Expt Med, I-00161 Rome, Italy
[3] Ist Italiano Tecnol, Ctr Life Nano Sci Sapienza, I-00161 Rome, Italy
关键词
microRNA; Notch; Natural Killer cells; T and regulatory T cells; MDSC; Acute lymphoblastic leukaemia; SUPPRESSOR-CELLS; TUMOR-SUPPRESSOR; MOLECULAR-MECHANISMS; NK CELLS; NOTCH; EXPRESSION; ACTIVATION; INFLAMMATION; REVEALS; EVASION;
D O I
10.3390/ijms23020829
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Acute lymphoblastic leukaemia (ALL) is an aggressive haematological tumour driven by the malignant transformation and expansion of B-cell (B-ALL) or T-cell (T-ALL) progenitors. The evolution of T-ALL pathogenesis encompasses different master developmental pathways, including the main role played by Notch in cell fate choices during tissue differentiation. Recently, a growing body of evidence has highlighted epigenetic changes, particularly the altered expression of microRNAs (miRNAs), as a critical molecular mechanism to sustain T-ALL. The immune response is emerging as key factor in the complex multistep process of cancer but the role of miRNAs in anti-leukaemia response remains elusive. In this review we analyse the available literature on miRNAs as tuners of the immune response in T-ALL, focusing on their role in Natural Killer, T, T-regulatory and Myeloid-derived suppressor cells. A better understanding of this molecular crosstalk may provide the basis for the development of potential immunotherapeutic strategies in the leukemia field.
引用
收藏
页数:19
相关论文
共 50 条
  • [41] Early response and outcomes of bone marrow to chemotherapy in T-Cell Acute Lymphoblastic Leukemia
    Almoshary, May
    Altahan, Shatha Mahmoud
    Alswayyed, Aziza Fayed
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2024, 40 (05) : 979 - 984
  • [42] Acute Leukemia with Lineage Switch From Acute Myeloid Leukemia to T-Cell Acute Lymphoblastic Leukemia
    Sajiki, Daichi
    Tsuchiya, Kento
    Yamashita, Daiki
    Kitazawa, Hironobu
    Sakaguchi, Hirotoshi
    Yoshida, Nao
    Ito, Tsuyoshi
    Hama, Asahito
    PEDIATRIC BLOOD & CANCER, 2020, 67
  • [43] A case of T-cell acute lymphoblastic leukemia after treatment of acute promyelocytic leukemia
    Bee, PC
    Gan, GG
    Sangkar, JV
    Teh, A
    Goh, KY
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2004, 79 (04) : 358 - 360
  • [44] A Case of T-Cell Acute Lymphoblastic Leukemia after Treatment of Acute Promyelocytic Leukemia
    P. C. Bee
    G. G. Gan
    J. V. Sangkar
    A. Teh
    K. Y. Goh
    International Journal of Hematology, 2004, 79 : 358 - 360
  • [45] Leukemic relapse as T-cell acute lymphoblastic leukemia in a patient with acute myeloid leukemia and a minor T-cell clone at diagnosis
    Bellido, M
    Martino, R
    Aventín, A
    Carnicer, MJ
    Rubiol, E
    López, O
    Sierra, J
    Nomdedéu, JF
    HAEMATOLOGICA, 2000, 85 (10) : 1083 - 1086
  • [46] COMBINED T-CELL AND B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
    HAEGERT, DG
    CAWLEY, JC
    KARPAS, A
    GOLDSTONE, AH
    BMJ-BRITISH MEDICAL JOURNAL, 1974, 4 (5936): : 79 - 82
  • [47] B-CELL AND T-CELL ASSAYS IN ACUTE LYMPHOBLASTIC LEUKEMIA
    DEVEBER, LL
    BELL, DA
    PEDIATRIC RESEARCH, 1978, 12 (04) : 479 - 479
  • [48] CELL FREE TARGETED THERAPY FOR T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
    Neethling, Jacob
    Shao, Lijian
    Zhang, Endong
    Zhao, Zongmin
    Pear, Warren
    Pajcini, Kostandin
    EXPERIMENTAL HEMATOLOGY, 2024, 137
  • [49] Cell Free Targeted Therapy for T-cell Acute Lymphoblastic Leukemia
    Neethling, Jacob
    Pajcini, Kostandin
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2023, 385
  • [50] Genomic imbalances in T-cell acute lymphoblastic leukemia cell lines
    Gebhart, E
    Thoma, K
    Verdorfer, I
    Drexler, HG
    Efferth, T
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2002, 21 (04) : 887 - 894